Athe Michaelnoel Tsibris MD
Assistant Professor of Medicine, Brigham and Women's Hospital
Join to View Full Profile
55 Fruit StreetGrj 504Boston, MA 02114
Phone+1 617-726-3812
Fax+1 617-726-7416
Dr. Tsibris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 2002 - 2006
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1998 - 2002
University of South Florida College of MedicineClass of 1998
Certifications & Licensure
MA State Medical License 2004 - 2025
IL State Medical License 1998 - 2002
American Board of Internal Medicine Infectious Disease
Clinical Trials
- Pharmacokinetics and Safety of SAR441236 Start of enrollment: 2019 May 20
Publications & Presentations
PubMed
- Deactivated Cas9-Engineered Magnetic Micromotors toward a Point-of-Care Digital Viral RNA Assay.Younseong Song, Hyunji Park, Prudhvi Thirumalaraju, Niveditha Kovilakath, Joseph Michael Hardie
ACS Nano. 2025-03-11 - HIV-1 latency reversal agent boosting is not limited by opioid use.Tyler Lilie, Jennifer Bouzy, Archana Asundi, Jessica Taylor, Samantha Roche
JCI Insight. 2024-11-22 - HIV-1 latency reversal agent boosting is not limited by opioid use.Tyler Lilie, Jennifer Bouzy, Archana Asundi, Jessica Taylor, Samantha Roche
Medrxiv. 2024-06-04
Journal Articles
- Publisher Correction: Evidence That CD32a Does Not Mark the HIV-1 Latent ReservoirAthe Tsibris, MD, Nature
Press Mentions
The Rise and Fall of PaxlovidApril 9th, 2024
Grant Support
- High-Definition Characterization of the Persistence and Perturbation of the HIV ReservoirBRIGHAM AND WOMEN'S HOSPITAL2022–2027
- HIV-1 dynamics and evolution during trispecific broadly neutralizing antibody therapyBRIGHAM AND WOMEN'S HOSPITAL2021–2026
- HIV-2 latency and its reversalBRIGHAM AND WOMEN'S HOSPITAL2021–2026
- The effects of opioid use on HIV-1 reservoir dynamicsBRIGHAM AND WOMEN'S HOSPITAL2018–2025
- Dynamic HIV-1 Escape From CCR5 Antagonism In VitoNational Institute Of Allergy And Infectious Diseases2011
- Dynamic HIV-1 Escape From CCR5 Antagonism In VitoNational Institute Of Allergy And Infectious Diseases2009–2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
